4.2 Article

Changes in Cancer Treatment Mabs, Mibs, Mids, Nabs, and Nibs

期刊

NURSING CLINICS OF NORTH AMERICA
卷 52, 期 1, 页码 65-+

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.cnur.2016.10.004

关键词

Monoclonal antibody; Nanoparticle albumin-bound drug; Tyrosine kinase inhibitor; Immunomodulatory drug; Proteasome inhibitor; Cancer therapeutics; Targeted therapy; Nursing care

类别

向作者/读者索取更多资源

Cancer therapeutics has been growing in an unprecedented fashion and has evolved rapidly in the past two decades. Specific gene mutation, protein dysfunction and dysregulation, intracellular signaling pathways, and immune modulation have been targeted. These therapeutic advances came largely because of improved understanding of the pathobiology of cancer at the genetic and molecular levels. This article addresses the need of novice nurses for cancer treatment related information and evidence -based nursing care of patients diagnosed with cancer while undergoing novel and breakthrough therapeutics.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据